Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Sex hormone-binding globulin (SHBG) expression in ovarian carcinomas and its clinicopathological associations.

Huang R, Ma Y, Holm R, Trope CG, Nesland JM, Suo Z.

PLoS One. 2013 Dec 26;8(12):e83238. doi: 10.1371/journal.pone.0083238. eCollection 2013.

2.

Age-dependent sex hormone-binding globulin expression in male rat.

Li Y, Li X, Fan H, Li X, Zhong Y, Cao J, Yu D, Zhang M, Wen JG, Geng L, Suo Z.

Ultrastruct Pathol. 2015 Apr;39(2):121-30. doi: 10.3109/01913123.2015.1009222.

PMID:
25879298
3.

SHBG is an important factor in stemness induction of cells by DHT in vitro and associated with poor clinical features of prostate carcinomas.

Ma Y, Liang D, Liu J, Wen JG, Servoll E, Waaler G, Sæter T, Axcrona K, Vlatkovic L, Axcrona U, Paus E, Yang Y, Zhang Z, Kvalheim G, Nesland JM, Suo Z.

PLoS One. 2013 Jul 30;8(7):e70558. doi: 10.1371/journal.pone.0070558. Print 2013.

4.

Sex hormone binding globulin mRNA in human breast cancer: detection in cell lines and tumor samples.

Moore KH, Bertram KA, Gomez RR, Styner MJ, Matej LA.

J Steroid Biochem Mol Biol. 1996 Nov;59(3-4):297-304.

PMID:
9010321
5.

Expression of sex hormone-binding globulin mRNA in human ovarian cancers.

Misao R, Nakanishi Y, Fujimoto J, Hori M, Ichigo S, Tamaya T.

Eur J Endocrinol. 1995 Sep;133(3):327-34.

PMID:
7581950
6.

Immunolocalization of sex hormone-binding globulin (SHBG) in human ovarian follicles and corpus luteum.

Forges T, Gérard A, Monnier-Barbarino P, Gérard H.

Histochem Cell Biol. 2005 Sep;124(3-4):285-90. Epub 2005 Oct 28.

PMID:
16028066
7.

Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene.

Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, Arlt K, Zhumabayeva B, Siebert PD, Dietel M, Schäfer R, Sers C.

Am J Pathol. 2001 Nov;159(5):1635-43.

8.

Sex hormone-binding globulin, its membrane receptor, and breast cancer: a new approach to the modulation of estradiol action in neoplastic cells.

Fortunati N, Becchis M, Catalano MG, Comba A, Ferrera P, Raineri M, Berta L, Frairia R.

J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):473-9. Review.

PMID:
10419027
9.

Expression of sex hormone-binding globulin (SHBG) in human granulosa-lutein cells.

Forges T, Gérard A, Hess K, Monnier-Barbarino P, Gérard H.

Mol Cell Endocrinol. 2004 Apr 30;219(1-2):61-8.

PMID:
15149727
10.

Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study.

Garcia-Closas M, Brinton LA, Lissowska J, Richesson D, Sherman ME, Szeszenia-Dabrowska N, Peplonska B, Welch R, Yeager M, Zatonski W, Chanock SJ.

BMC Cancer. 2007 Apr 5;7:60.

11.

Distribution of immunoreactive androgen-binding protein/sex hormone-binding globulin in tissues of the fetal rat.

Becchis M, Sullivan PM, Ordronneau P, Petrusz P, Joseph DR.

Steroids. 1996 Jul;61(7):392-400.

PMID:
8837290
12.

Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylation.

Akahira J, Suzuki F, Suzuki T, Miura I, Kamogawa N, Miki Y, Ito K, Yaegashi N, Sasano H.

Pathol Int. 2007 Nov;57(11):725-33.

PMID:
17922684
13.

High GOLPH3 expression is associated with a more aggressive behavior of epithelial ovarian carcinoma.

Ma Y, Ren Y, Zhang X, Lin L, Liu Y, Rong F, Wen W, Li F.

Virchows Arch. 2014 Apr;464(4):443-52. doi: 10.1007/s00428-014-1536-3. Epub 2014 Jan 24.

PMID:
24458516
14.

Human sex hormone-binding globulin gene expression- multiple promoters and complex alternative splicing.

Nakhla AM, Hryb DJ, Rosner W, Romas NA, Xiang Z, Kahn SM.

BMC Mol Biol. 2009 May 5;10:37. doi: 10.1186/1471-2199-10-37.

15.

Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma.

Mao TL, Hsu CY, Yen MJ, Gilks B, Sheu JJ, Gabrielson E, Vang R, Cope L, Kurman RJ, Wang TL, Shih IeM.

Hum Pathol. 2006 Sep;37(9):1169-75. Epub 2006 Jul 7.

PMID:
16938522
16.

Dominant expression of sex-hormone-binding-globulin exon-7 splicing variant over wild-type mRNA in human ovarian cancers.

Misao R, Nakanishi Y, Fujimoto J, Iwagaki S, Tamaya T.

Int J Cancer. 1998 Sep 11;77(6):828-32.

17.

Prospective study of sex hormone levels and risk of prostate cancer.

Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ.

J Natl Cancer Inst. 1996 Aug 21;88(16):1118-26.

18.
20.

Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.

Salonia A, Gallina A, Briganti A, Zanni G, Suardi N, Capitanio U, Colombo R, Bertini R, Freschi M, Guazzoni G, Rigatti P, Montorsi F.

BJU Int. 2011 Apr;107(8):1243-9. doi: 10.1111/j.1464-410X.2010.09582.x. Epub 2010 Sep 30.

Items per page

Supplemental Content

Write to the Help Desk